Debt-to-equity of Anebulo Pharmaceuticals, Inc. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Anebulo Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 31 Dec 2021 to 31 Dec 2025.
Anebulo Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 8.1%, a 23% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Anebulo Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	8.1%	-2.5%	-23%	31 Dec 2025
Q3 2025	5.8%	-11%	-65%	30 Sep 2025
Q2 2025	5.9%	-6.8%	-53%	30 Jun 2025
Q1 2025	6.6%	-5.9%	-47%	31 Mar 2025
Q4 2024	11%	-0.59%	-5.2%	31 Dec 2024
Q3 2024	17%	+6.8%	+69%	30 Sep 2024
Q2 2024	13%	+4.8%	+60%	30 Jun 2024
Q1 2024	13%	+6%	+93%	31 Mar 2024
Q4 2023	11%	+7.2%	+180%	31 Dec 2023
Q3 2023	9.8%	+7.9%	+412%	30 Sep 2023
Q2 2023	8%	+6.2%	+350%	30 Jun 2023
Q1 2023	6.5%	+5.2%	+411%	31 Mar 2023
Q4 2022	4%	-19%	-83%	31 Dec 2022
Q3 2022	1.9%			30 Sep 2022
Q2 2022	1.8%			30 Jun 2022
Q1 2022	1.3%			31 Mar 2022
Q4 2021	23%			31 Dec 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.